A new study reveals that inflammation during pregnancy may impair neurodevelopment in infants by reducing CD11c-positive ...
News Medical on MSN6d
Scientists uncover rare gene variants that help people live past 100Researchers studying over 2,000 Ashkenazi Jewish centenarians uncovered two rare IGF-1 gene variants linked to exceptional ...
SYCUME® (teprotumumab N01) is a recombinant anti-insulin-like growth factor 1 receptor (IGF-1R) antibody developed by Innovent for the treatment of TED. IGF-1R is a transmembrane tyrosine kinase ...
TipRanks on MSN19d
Innovent Biologics’ SYCUME® Gains Approval as China’s First IGF-1R Antibody for Thyroid Eye DiseaseAn announcement from Innovent Biologics ( ($HK:1801) ) is now available. Innovent Biologics has announced the approval of SYCUME®, China’s first ...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback